Equals 5 Secures Strategic Investment from Baleon Capital to Power the Industry’s Most Precise HCP Marketing Platform

NEW YORK, Feb. 12, 2025 /PRNewswire/ — Equals 5, the leading AdTech platform revolutionizing pharmaceutical and healthcare marketing is excited to announce a strategic growth equity investment from Baleon Capital. This investment marks a significant milestone in Equals 5’s mission to provide unparalleled, precisely targeted, and attributable HCP marketing solutions for the pharmaceutical industry.

With this partnership, Equals 5 will further enhance its innovative platform, which empowers pharmaceutical companies and agencies to seamlessly build audiences, execute campaigns, and precisely engage HCPs across 20+ channels in one place. Unlike traditional marketing approaches, Equals 5 leverages 100% NPI-level targeting and reporting to deliver unmatched performance transparency and campaign attribution.

“Our platform is transforming pharmaceutical marketing by delivering precisely targeted HCP campaigns across social media channels and beyond, with clear, attributable performance insights at the NPI level,” said Roman Makukh, Co-Founder and CEO at Equals 5. “With Baleon Capital’s investment, we will accelerate platform advancements, introduce AI-powered solutions, expand HCP reach across more channels with superior PLD, and much more – all aimed at scaling to meet the surging demand from our clients. We’re excited about what’s happening now and even more about the opportunities ahead.”

Baleon Capital specializes in supporting high-growth healthcare and B2B technology companies, providing both financial backing and strategic guidance. Their investment underscores the unique value and market differentiation of Equals 5’s AdTech solutions in an industry where precise, data-driven engagement with HCPs is essential.

As social media and non-endemic digital channels become increasingly crucial for HCP marketing and engagement, Equals 5’s ability to bridge the gap with proprietary targeting capabilities and NPI-level insights positions it as the go-to platform for pharmaceutical marketers looking to power their HCP campaigns and maximize ROI.

For more information about Equals 5 capabilities, visit www.equals5.com.

About Equals 5
Equals 5 is a pioneering provider of marketing and media buying solutions for the Pharma and Life Sciences industries. The Equals 5 All-in-One Healthcare Marketing Platform enables to easily set up and launch HCP marketing campaigns on 20+ channels in one place while using a unique 100% NPI-level targeting technology to precisely reach the HCPs on your target lists and gather NPI-level reporting data on all engagements.

About Baleon Capital
Baleon Capital specializes in investing in early-growth stage healthcare and B2B technology companies, providing both capital and operational support to accelerate success. Focusing on businesses with strong revenue growth and innovative market positioning, Baleon Capital partners with founders to scale their companies from initial investment through exit.

Follow us on LinkedIn: Equals 5 | Baleon Capital

For press inquiries, please contact:
Julia Tsymbaliuk
Marketing Director
Equals 5
julia.tsymbaliuk@equals5.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/equals-5-secures-strategic-investment-from-baleon-capital-to-power-the-industrys-most-precise-hcp-marketing-platform-302374824.html

SOURCE Equals 5